Vaccines derived from epithelial cell mucin MUC-1

Details for Australian Patent Application No. 2004215187 (hide)

Owner Glaxo Group Limited

Inventors Hamblin, Paul Andrew; Rocha Del Cura, Maria De Los Angeles

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004215187

PCT Pub. Number WO2004/076665

Priority 0304634.9 28.02.03 GB

Filing date 26 February 2004

Wipo publication date 10 September 2004

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07K 014/47 Peptides having more than 20 amino acids

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/076665 Priority application(s): WO2004/076665

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215193-Construction safety assembly

2004215186-Device and method for generating stationary waves in flowing water